Morepen Labs.

Market Cap: Small Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE083A01026
NSEID: MOREPENLAB
BSEID: 500288

INR

41.54

0.01 (0.02%)

BSENSE

Dec 15

BSE+NSE Vol: 10.47 lacs

{
  "main_header": {
    "sid": 546345,
    "name": "Morepen Labs.",
    "stock_name": "Morepen Labs.",
    "full_name": "Morepen Laboratories Ltd",
    "name_url": "stocks-analysis/morepen-labs",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "41.54",
    "chg": 0.01,
    "chgp": "0.02%",
    "dir": 1,
    "prev_price": "41.53",
    "mcapval": "2,252.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 500288,
    "symbol": "MOREPENLAB",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE083A01026",
    "curr_date": "Dec 15",
    "curr_time": "",
    "bse_nse_vol": "10.47 lacs",
    "exc_status": "Active",
    "traded_date": "Dec 15, 2025",
    "traded_date_str": "2025 12 15",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/morepen-labs-546345-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Morepen Laboratories Stock Falls to 52-Week Low of Rs.40.01 Amidst Prolonged Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/morepen-laboratories-stock-falls-to-52-week-low-of-rs4001-3753575",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/MorepenLaborato_priceRelatedfactors_3753575.png",
        "date": "2025-12-09 10:13:26",
        "description": "Morepen Laboratories has reached a new 52-week low of Rs.40.01, marking a significant decline amid a sustained downward trajectory. The stock has underperformed its sector and broader market indices, reflecting ongoing pressures on the company’s financial performance and market sentiment."
      },
      {
        "title": "Morepen Laboratories Stock Falls to 52-Week Low of Rs.41.33",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/morepen-laboratories-stock-falls-to-52-week-low-of-rs4133-3751174",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/MorepenLaborato_priceRelatedfactors_3751174.png",
        "date": "2025-12-08 10:53:21",
        "description": "Shares of Morepen Laboratories touched a fresh 52-week low of Rs.41.33 today, marking a significant decline amid broader market fluctuations and sectoral pressures. The stock has been underperforming the Pharmaceuticals & Biotechnology sector and continues to trade below all major moving averages."
      },
      {
        "title": "Morepen Laboratories Stock Hits 52-Week Low at Rs.41.33 Amidst Prolonged Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/morepen-laboratories-stock-falls-to-52-week-low-of-rs4133-3751172",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/MorepenLaborato_priceRelatedfactors_3751172.png",
        "date": "2025-12-08 10:53:16",
        "description": "Morepen Laboratories has reached a new 52-week low of Rs.41.33, marking a significant decline amid ongoing downward momentum. The stock has underperformed its sector and broader market indices, reflecting persistent challenges in its financial performance over the past year."
      },
      {
        "title": "Morepen Laboratories Faces Challenging Market Conditions Amid Mixed Financial and Technical Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/morepen-laboratories-downgraded-to-strong-sell-amid-weak-financials-and-bearish-technicals-3727841",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/MorepenLaborato_mojoScore_3727841.png",
        "date": "2025-11-25 08:42:08",
        "description": "Morepen Laboratories, a player in the Pharmaceuticals & Biotechnology sector, is currently navigating a complex market environment marked by subdued financial results and cautious technical indicators. Recent shifts in evaluation metrics reflect a nuanced perspective on the company’s quality, valuation, financial trends, and technical outlook, underscoring the challenges it faces amid broader market dynamics."
      },
      {
        "title": "Why is Morepen Labs. falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-morepen-labs-fallingrising-3726924",
        "imagepath": "",
        "date": "2025-11-25 01:15:32",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Comparison</strong></p>\n<p>On 24 November, Morepen Laboratories closed at ₹43.10, down by ₹0.91 or 2.07% from the previous session. This drop continues a downward trend, with the stock having fallen for eight consecutive days, resulting in an 8.57% loss over this period. The stock is trading close to its 52-week low, just 3.34% above the lowest price of ₹41.66 recorded during the past year. This proximity to the annual low signals persistent selling pressure and a lack of positive catalysts to reverse the trend.</p>\n<p>When compared to the broader market, Morepen Laboratories has significantly underperformed. Over the past week, the stock declined by 6.77%, while the Sensex remained virtually flat with a marginal 0.06% gain. The one-month performance further ..."
      },
      {
        "title": "How has been the historical performance of Morepen Labs.?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-morepen-labs-3726354",
        "imagepath": "",
        "date": "2025-11-24 23:14:10",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Revenue and Profit Growth</strong></p>\n<p>Morepen Labs’ net sales have shown a consistent upward trend, increasing from ₹768.54 crores in March 2019 to ₹1,811.58 crores in March 2025. This represents a more than twofold increase over six years, reflecting the company’s expanding market presence and product portfolio. Despite a slight dip in sales in March 2022 compared to the previous year, the overall trajectory remains positive.</p>\n<p>Operating profit before depreciation and interest (PBDIT) excluding other income rose from ₹67.52 crores in 2019 to ₹174.07 crores in 2025, indicating improved operational efficiency. Including other income, operating profit increased to ₹192.43 crores in the latest fiscal year. Profit after tax (PAT) also followed a similar pattern, climbing from ₹28.84 cro..."
      },
      {
        "title": "Is Morepen Labs. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-morepen-labs-technically-bullish-or-bearish-3716888",
        "imagepath": "",
        "date": "2025-11-20 08:11:09",
        "description": "As of 19 November 2025, the technical trend for Morepen Labs has changed from mildly bearish to bearish. The current stance is bearish with moderate strength. The weekly MACD is bearish, and the daily moving averages confirm this bearish outlook. Bollinger Bands are also indicating a bearish trend on both weekly and monthly time frames. The KST shows a mildly bullish signal on the weekly but is mildly bearish on the monthly, indicating some mixed signals. Overall, the Dow Theory supports a mildly bearish view on both weekly and monthly time frames. The stock has underperformed significantly against the Sensex over various periods, further reinforcing the bearish sentiment...."
      },
      {
        "title": "Morepen Laboratories Technical Momentum Shifts Amid Bearish Indicators",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/morepen-laboratories-technical-momentum-shifts-amid-bearish-signals-3716988",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/MorepenLaborato_technicaldot_3716988.png",
        "date": "2025-11-20 08:04:29",
        "description": "Morepen Laboratories has experienced a notable shift in its technical momentum, with recent evaluation adjustments reflecting a predominantly bearish outlook across key indicators. This article analyses the current technical signals, price movements, and comparative returns to provide a comprehensive view of the stock’s market position within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Why is Morepen Labs. falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-morepen-labs-fallingrising-3716355",
        "imagepath": "",
        "date": "2025-11-19 23:10:57",
        "description": "As of 19-Nov, Morepen Laboratories Ltd is experiencing a decline in its stock price, currently at 45.52, reflecting a decrease of 0.22 or 0.48%. The stock has underperformed its sector by 0.55% today and has been on a consecutive downward trend for the last five days, resulting in a total decline of 3.44% over that period. Additionally, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Over the past year, the stock has generated a return of -40.00%, while its profits have fallen by 42.6%. The company has also reported negative results for the last three consecutive quarters, contributing to a lack of investor confidence, as indicated by the low participation from domestic mutual funds.\n\nIn the broader market context, the stock's recent performance contrasts sharply with the benchmark Sensex, which has gained 0.85% over the past week and 1.47% over the past month. Wh..."
      }
    ],
    "total": 351,
    "sid": "546345",
    "stock_news_url": "https://www.marketsmojo.com/news/morepen-laboratories-546345"
  },
  "announcements": [
    {
      "caption": "Disclosure Under Regulation 30 (LODR)",
      "datetime": "04-Dec-2025",
      "details": "Disclosure under Regulation 30 (LODR)",
      "source": "BSE"
    },
    {
      "caption": "Report On Transfer Requests Of Physical Shares Re-Lodged Under The Special Window",
      "datetime": "01-Dec-2025",
      "details": "Please find attached the report for the month of November 2025",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "15-Nov-2025",
      "details": "Newspaper Publication-Financial Results for the quarter and half year ended September 30 2025",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Morepen Laboratories Ltd has declared <strong>10%</strong> dividend, ex-date: 29 Aug 25",
          "dt": "2025-08-29",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Morepen Laboratories Stock Falls to 52-Week Low of Rs.40.01 Amidst Prolonged Downtrend

2025-12-09 10:13:26

Morepen Laboratories has reached a new 52-week low of Rs.40.01, marking a significant decline amid a sustained downward trajectory. The stock has underperformed its sector and broader market indices, reflecting ongoing pressures on the company’s financial performance and market sentiment.

Morepen Laboratories Stock Falls to 52-Week Low of Rs.41.33

2025-12-08 10:53:21

Shares of Morepen Laboratories touched a fresh 52-week low of Rs.41.33 today, marking a significant decline amid broader market fluctuations and sectoral pressures. The stock has been underperforming the Pharmaceuticals & Biotechnology sector and continues to trade below all major moving averages.

Morepen Laboratories Stock Hits 52-Week Low at Rs.41.33 Amidst Prolonged Downtrend

2025-12-08 10:53:16

Morepen Laboratories has reached a new 52-week low of Rs.41.33, marking a significant decline amid ongoing downward momentum. The stock has underperformed its sector and broader market indices, reflecting persistent challenges in its financial performance over the past year.

Morepen Laboratories Faces Challenging Market Conditions Amid Mixed Financial and Technical Signals

2025-11-25 08:42:08

Morepen Laboratories, a player in the Pharmaceuticals & Biotechnology sector, is currently navigating a complex market environment marked by subdued financial results and cautious technical indicators. Recent shifts in evaluation metrics reflect a nuanced perspective on the company’s quality, valuation, financial trends, and technical outlook, underscoring the challenges it faces amid broader market dynamics.

Why is Morepen Labs. falling/rising?

2025-11-25 01:15:32

Recent Price Movement and Market Comparison

On 24 November, Morepen Laboratories closed at ₹43.10, down by ₹0.91 or 2.07% from the previous session. This drop continues a downward trend, with the stock having fallen for eight consecutive days, resulting in an 8.57% loss over this period. The stock is trading close to its 52-week low, just 3.34% above the lowest price of ₹41.66 recorded during the past year. This proximity to the annual low signals persistent selling pressure and a lack of positive catalysts to reverse the trend.

When compared to the broader market, Morepen Laboratories has significantly underperformed. Over the past week, the stock declined by 6.77%, while the Sensex remained virtually flat with a marginal 0.06% gain. The one-month performance further ...

How has been the historical performance of Morepen Labs.?

2025-11-24 23:14:10

Revenue and Profit Growth

Morepen Labs’ net sales have shown a consistent upward trend, increasing from ₹768.54 crores in March 2019 to ₹1,811.58 crores in March 2025. This represents a more than twofold increase over six years, reflecting the company’s expanding market presence and product portfolio. Despite a slight dip in sales in March 2022 compared to the previous year, the overall trajectory remains positive.

Operating profit before depreciation and interest (PBDIT) excluding other income rose from ₹67.52 crores in 2019 to ₹174.07 crores in 2025, indicating improved operational efficiency. Including other income, operating profit increased to ₹192.43 crores in the latest fiscal year. Profit after tax (PAT) also followed a similar pattern, climbing from ₹28.84 cro...

Is Morepen Labs. technically bullish or bearish?

2025-11-20 08:11:09

As of 19 November 2025, the technical trend for Morepen Labs has changed from mildly bearish to bearish. The current stance is bearish with moderate strength. The weekly MACD is bearish, and the daily moving averages confirm this bearish outlook. Bollinger Bands are also indicating a bearish trend on both weekly and monthly time frames. The KST shows a mildly bullish signal on the weekly but is mildly bearish on the monthly, indicating some mixed signals. Overall, the Dow Theory supports a mildly bearish view on both weekly and monthly time frames. The stock has underperformed significantly against the Sensex over various periods, further reinforcing the bearish sentiment....

Morepen Laboratories Technical Momentum Shifts Amid Bearish Indicators

2025-11-20 08:04:29

Morepen Laboratories has experienced a notable shift in its technical momentum, with recent evaluation adjustments reflecting a predominantly bearish outlook across key indicators. This article analyses the current technical signals, price movements, and comparative returns to provide a comprehensive view of the stock’s market position within the Pharmaceuticals & Biotechnology sector.

Why is Morepen Labs. falling/rising?

2025-11-19 23:10:57

As of 19-Nov, Morepen Laboratories Ltd is experiencing a decline in its stock price, currently at 45.52, reflecting a decrease of 0.22 or 0.48%. The stock has underperformed its sector by 0.55% today and has been on a consecutive downward trend for the last five days, resulting in a total decline of 3.44% over that period. Additionally, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Over the past year, the stock has generated a return of -40.00%, while its profits have fallen by 42.6%. The company has also reported negative results for the last three consecutive quarters, contributing to a lack of investor confidence, as indicated by the low participation from domestic mutual funds. In the broader market context, the stock's recent performance contrasts sharply with the benchmark Sensex, which has gained 0.85% over the past week and 1.47% over the past month. Wh...

View All News